India  
 
NewsR.in

J&J, AstraZeneca resuming trials of vaccines

Video Credit: Reuters Studio - Duration: 01:08s - Published
J&J, AstraZeneca resuming trials of vaccines

J&J, AstraZeneca resuming trials of vaccines

AstraZeneca has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week, the companies said on Friday.

Fred Katayama reports.


You Might Like


Related videos from verified sources

COVID-19 vaccine trial progressing with help from Valley participants [Video]

COVID-19 vaccine trial progressing with help from Valley participants

America's attention is on Election Day right now, but an equally impactful decision is happening behind the scenes with COVID-19 vaccines.

Credit: ABC15 Arizona     Duration: 02:21Published
Daily Covid-19 Minute: Astrazeneca’s Vaccine Trial Has Been On Pause For 6 Weeks, Here’s What We Know [Video]

Daily Covid-19 Minute: Astrazeneca’s Vaccine Trial Has Been On Pause For 6 Weeks, Here’s What We Know

Some good news in our race for a COVID-19 vaccine. Both Johnson & Johnson and Astrazeneca have announced they’re resuming phase 3 trials for their respective COVID vaccines.

Credit: CBS 62 Detroit     Duration: 01:08Published
AstraZeneca Covid-19 Vaccine Trial Showing Promising Results [Video]

AstraZeneca Covid-19 Vaccine Trial Showing Promising Results

AstraZeneca's Covid-19 vaccine trial has shown promise producing antibodies in adult and elderly patients, a sign that a viable vaccine could be ready by year-end.

Credit: The Street     Duration: 02:03Published